{"disease":{"id":"healthy-adult-male-volunteers","name":"healthy adult male volunteers"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07413666","title":"A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":212,"lead_sponsor_name":"Centessa Pharmaceuticals (UK) Limited","has_results":false},{"nct_id":"NCT07445113","title":"Diaphragmatic Breathing and Stimulation of the Autonomic Nervous System","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Jaén","has_results":false},{"nct_id":"NCT06482346","title":"Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":false},{"nct_id":"NCT07251153","title":"Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Enyo Pharma","has_results":false},{"nct_id":"NCT07412080","title":"EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Eddingpharm (Zhuhai) Co., Ltd.","has_results":false},{"nct_id":"NCT06935682","title":"Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07146711","title":"A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady State","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":33,"lead_sponsor_name":"Berlin-Chemie AG Menarini Group","has_results":false},{"nct_id":"NCT07269873","title":"Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"BioCorRx Pharmaceuticals Inc","has_results":false},{"nct_id":"NCT04873063","title":"Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"SOFAR S.p.A.","has_results":false},{"nct_id":"NCT07201584","title":"A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Berlin-Chemie AG Menarini Group","has_results":false},{"nct_id":"NCT03381664","title":"Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Avanir Pharmaceuticals","has_results":false},{"nct_id":"NCT07313332","title":"Exploring Resistance Exercise Training Plus High-Intensity Interval Training (ReHIIT) as Cancer Prehabilitation","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":14,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT04341077","title":"Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05905653","title":"Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Santen Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05095337","title":"Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male Volunteers","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":6,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05150717","title":"ADME Study of [14C]-Jaktinib in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","has_results":false},{"nct_id":"NCT04616742","title":"Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT04260373","title":"Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05059743","title":"ADME Study of [14C]- Larotinib in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT05109078","title":"ADME Study of [14C]- Rongliflozin in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}